4.6 Review

Putting Infection Dynamics at the Heart of Chagas Disease

期刊

TRENDS IN PARASITOLOGY
卷 32, 期 11, 页码 899-911

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.pt.2016.08.009

关键词

-

资金

  1. Wellcome Trust [084175]
  2. British Heart Foundation [PG/13/88/30556]
  3. Drugs for Neglected Diseases Initiative
  4. European Commission Marie Curie Individual Fellowships programme
  5. Division of Intramural Research, NIAID, NIH
  6. British Heart Foundation [PG/13/88/30556] Funding Source: researchfish

向作者/读者索取更多资源

In chronic Trypanosoma cruzi infections, parasite burden is controlled by effective, but nonsterilising immune responses. Infected cells are difficult to detect because they are scarce and focally distributed in multiple sites. However, advances in detection technologies have established a link between parasite persistence and the pathogenesis of Chagas heart disease. Long-term persistence likely involves episodic reinvasion as well as continuous infection, to an extent that varies between tissues. The primary reservoir sites in humans are not definitively known, but analysis of murine models has identified the gastrointestinal tract. Here, we highlight that quantitative, spatial, and temporal aspects of T. cruzi infection are central to a fuller understanding of the association between persistence, pathogenesis, and immunity, and for optimising treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole

Monica C. Campos, Jody Phelan, Amanda F. Francisco, Martin C. Taylor, Michael D. Lewis, Arnab Pain, Taane G. Clark, John M. Kelly

SCIENTIFIC REPORTS (2017)

Article Infectious Diseases

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery

Lorna M. MacLean, John Thomas, Michael D. Lewis, Ignacio Cotillo, David W. Gray, Manu De Rycker

PLOS NEGLECTED TROPICAL DISEASES (2018)

Article Infectious Diseases

Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping

Fernanda Cristina Costa, Amanda Fortes Francisco, Shiromani Jayawardhana, Simone Guedes Calderano, Michael D. Lewis, Francisco Olmo, Tom Beneke, Eva Gluenz, Jack Sunter, Samuel Dean, John Morrison Kelly, Martin Craig Taylor

PLOS NEGLECTED TROPICAL DISEASES (2018)

Article Endocrinology & Metabolism

Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas disease

K. Hennig, J. Abi-Ghanem, A. Bunescu, X. Meniche, E. Biliaut, A. D. Ouattara, M. D. Lewis, J. M. Kelly, S. Braillard, G. Courtemanche, E. Chatelain, F. Bequet

METABOLOMICS (2019)

Article Infectious Diseases

Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection

Martin C. Taylor, Alexander Ward, Francisco Olmo, Shiromani Jayawardhana, Amanda F. Francisco, Michael D. Lewis, John M. Kelly

PLOS NEGLECTED TROPICAL DISEASES (2020)

Review Biochemistry & Molecular Biology

Challenges in Chagas Disease Drug Development

Amanda F. Francisco, Shiromani Jayawardhana, Francisco Olmo, Michael D. Lewis, Shane R. Wilkinson, Martin C. Taylor, John M. Kelly

MOLECULES (2020)

Review Immunology

Host-parasite dynamics in Chagas disease from systemic to hyper-local scales

Damian Perez-Mazliah, Alexander I. Ward, Michael D. Lewis

Summary: Trypanosoma cruzi is a versatile parasite that can parasitize almost any nucleated cell type and naturally infects a variety of mammal species, causing Chagas disease. While a large number of people are infected, around two thirds of them remain long-term asymptomatic carriers. Clinical outcomes of chronic infections depend on the interactions between host and parasite.

PARASITE IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug Activity

Martin C. Taylor, Alexander Ward, Francisco Olmo, Amanda F. Francisco, Shiromani Jayawardhana, Fernanda C. Costa, Michael D. Lewis, John M. Kelly

Summary: Chagas disease is caused by infection with the trypanosomatid parasite Trypanosoma cruzi. Challenges in developing new drugs have been posed by the long term and complex nature of the condition and limited understanding of parasite biology. The development of noninvasive, highly sensitive bioluminescence imaging procedures based on red-shifted luciferase-expressing parasites has greatly improved infection monitoring and driven drug development.

CURRENT PHARMACEUTICAL DESIGN (2021)

Article Genetics & Heredity

Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexity

Philipp Schwabl, Jalil Maiguashca Sanchez, Jaime A. Costales, Sofia Ocana-Mayorga, Maikell Segovia, Hernan J. Carrasco, Carolina Hernandez, Juan David Ramirez, Michael D. Lewis, Mario J. Grijalva, Martin S. Llewellyn

PLOS GENETICS (2020)

Article Immunology

Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi

Carlos Talavera-Lopez, Louisa A. Messenger, Michael D. Lewis, Matthew Yeo, Joao Luis Reis-Cunha, Gabriel Machado Matos, Daniella C. Bartholomeu, Jose E. Calzada, Azael Saldana, Juan David Ramirez, Felipe Guhl, Sofia Ocana-Mayorga, Jaime A. Costales, Rodion Gorchakov, Kathryn Jones, Melissa S. Nolan, Santuza M. R. Teixeira, Hernan Jose Carrasco, Maria Elena Bottazzi, Peter J. Hotez, Kristy O. Murray, Mario J. Grijalva, Barbara Burleigh, Edmundo C. Grisard, Michael A. Miles, Bjorn Andersson

Summary: Trypanosoma cruzi, the causative agent of Chagas disease, has a complex and highly plastic genome, with surface molecules playing key roles in cell invasion, immune evasion, and pathogenesis. The genome assembly of the reference genome sequence for T. cruzi clade I has shed light on the unusual distribution and recombination mechanism of surface molecule genes, providing new insights into the population structure of T. cruzi.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale

Archie A. Khan, Harry C. Langston, Fernanda C. Costa, Francisco Olmo, Martin C. Taylor, Conor J. McCann, John M. Kelly, Michael D. Lewis

Summary: The study identified specific combinations of parasites and mice models that mimic symptoms of digestive Chagas disease in humans, particularly in the colon. By using genetically modified parasites, the research was able to track infection foci and nerve system lesions, highlighting the potential role of chronic infection and inflammation in the development of the disease.

PLOS PATHOGENS (2021)

Article Immunology

Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon

Alexander Ward, Michael D. Lewis, Martin C. Taylor, John M. Kelly

Summary: This study systematically analyzed the immunological microenvironments of parasitized cells in the mouse colon and found that incomplete recruitment of T cells to colonic infection foci allows the occurrence of repeated cycles of parasite replication and differentiation, leading to chronic infections.

INFECTION AND IMMUNITY (2022)

Article Biology

Microevolution of Trypanosoma cruzi reveals hybridization and clonal mechanisms driving rapid genome diversification

Gabriel Machado Matos, Michael D. Lewis, Carlos Talavera-Lopez, Matthew Yeo, Edmundo C. Grisard, Louisa A. Messenger, Michael Miles, Bjorn Andersson

Summary: The presence of genetic exchange in Trypanosoma cruzi has been controversial. Field studies and laboratory experiments have shown the existence of hybrids and hybrid progeny. Hybrid formation initially results in tetraploid parasites, but the progeny genomes gradually erode towards triploidy. However, elevated copy number is observed at several core housekeeping loci, indicating potential for adaptive evolution.
Article Biochemistry & Molecular Biology

Impact of Visceral Leishmaniasis on Local Organ Metabolism in Hamsters

Mahbobeh Lesani, Camil Gosmanov, Andrea Paun, Michael D. Lewis, Laura-Isobel Mccall

Summary: This study identified metabolites commonly impacted by Leishmania donovani infection across organs, including glycerophospholipids, ceramides, acylcarnitines, peptides, purines and amino acids. The comparison showed a greater overlap of perturbed metabolites between spleen and liver, in accordance with VL symptoms and parasite tropism.

METABOLITES (2022)

Article Cell Biology

The midgut microbiota plays an essential role in sand fly vector competence for Leishmania major

Isabelle Louradour, Carolina Cunha Monteiro, Ehud Inbar, Kashinath Ghosh, Richard Merkhofer, Phillip Lawyer, Andrea Paun, Margery Smelkinson, Nagila Secundino, Michael Lewis, Dinesh Erram, Ludek Zurek, David Sacks

CELLULAR MICROBIOLOGY (2017)

暂无数据